A review of the diagnosis and treatment of rosacea

Postgraduate Medicine

Volumn 122, Issue 1, 2010, Pages 139-143

  Scheinfeld, Noah ^a   Berk, Thomas ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Dermatological conditions; Inflammatory disease; Pharmacotherapy; Rosacea

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIPARASITIC AGENT; AZELAIC ACID; CLINDAMYCIN; CROTAMITON; DOXYCYCLINE; ERYTHROMYCIN; ISOTRETINOIN; IVERMECTIN; LINDANE; METRONIDAZOLE; PERMETHRIN; PIMECROLIMUS; RETINOL; SULFACETAMIDE; TETRACYCLINE DERIVATIVE;

ACNE VULGARIS; DIFFERENTIAL DIAGNOSIS; DRY SKIN; ERYTHEMA; FOOD AND DRUG ADMINISTRATION; HUMAN; PAIN; REVIEW; ROSACEA; SEBORRHEIC DERMATITIS; SKIN EDEMA;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DICARBOXYLIC ACIDS; HUMANS; LASER THERAPY; METRONIDAZOLE; PHYTOTHERAPY; ROSACEA; SUNSCREENING AGENTS; TETRACYCLINE;

EID: 76249114924     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.01.2107     Document Type: Review

References (47)

1. Scheinfeld NS. Rosacea. Skinmed. 2006;5(4):191-194.
2. Halder RM, Brooks HL, Callender VD. Acne in ethnic skin. Dermatol Clin. 2003;21(4):609-6l5, vii.
3. Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17(2):184-195.
4. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327-341.
5. Wilkin JK. Oral thermal-induced flushing in erythematotelangiectatic rosacea. J Invest Dermatol. 1981;76(1):15-18.
6. Higgins E, du Vivier A. Alcohol intake and other skin disorders. Clin Dermatol. 1999;17(4):437-441.
7. Brinnel H, Friedel J, Caputa M, Cabanac M, Grosshans E. Rosacea: disturbed defense against brain overheating. Arch Dermatol Res. 1989;281(1):66-72.
8. Greaves MW, Burova BE. Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol. 1997;8(2):91-100.
9. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584-587.
10. Bogetti P, Boltri M, Spagnoli G, Dolcet M. Surgical treatment of rhinophyma: a comparison of techniques. Aesthetic Plast Surg. 2002;26(1):57-60.
11. Lloyd KM. Surgical correction of rhinophyma. Arch Dermatol. 1990;126(6):721-723.
12. Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol. 1998;134(6):679-683.
13. Bjerke JR, Nyfors A, Austad J, Rajka G. Metronidazole (Elyzol) 1% cream vs. placebo cream in the treatment of rosacea. Clin Trials J. 1989;26:187-l94.
14. Breneman DL, Stewart D, Hevia O, Hino PD, Drake LA. A double-blind, multicenter clinical trial comparing efficacy of once-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis. 1998;61(1):44-47.
15. Jorizzo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol. 1998;39(3):502-504.
16. Colón LE, Johnson LA, Gottschalk RW. Cumulative irritation potential among metronidazole gel 1%, metronidazole gel 0.75%, and azelaic acid gel 15%. Cutis. 2007;79(4):317-321.
17. Elewski BE, Fleischer AB Jr, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dematol. 2003;139(11):1444-1450.
18. Maddin S. A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol. 1999;40(6 Pt 1):961-965.
19. Weissenbacher S, Merkl J, Hildebrandt B, et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol. 2007;156(4):728-732.
20. Chu CY. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. J Eur Acad Dermatol Venereol. 2007;21(4):484-490.
21. Bernard LA, Cunningham BB, Al-Suwaidan S, Friedlander SF, Eichenfield LF. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. Arch Dermatol. 2003;139(2):229-231.
22. Antille C, Saurat JH, Lübbe J. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol. 2004;140(4):457-460.
23. Dressler-Carre M. Acne vulgaris and rosacea. In: Arcangelo VP, Peterson AM, eds. Phamacotherapeutics in Advanced Practice: A Pracrical Approach. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2005.
24. Bikowski JB. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol. 2005;4(1):41-47.
25. Carlin RB. Topical vitamin C preparation reduces erythema of rosacea. Cosmetic Dermatology. 2001:35-38.
26. Shanler SD, Ondo AL. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha 1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol. 2007;143(11):1369-1371.
27. Wozniacka A, Wieczorkowska M, Gebicki J, Sysa-Jedrzejowska A. Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study. Clin Exp Dermatol. 2005;30(6):632-635.
28. Theobald K, Bradshaw M, Leyden J. Anti-inflammatory dose doxycydine (40 mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea. Skinmed. 2007;6(5):221-226.
29. Bakar O, Demirçay Z, Yuksel M, Haklar G, Sanisoglu Y. The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol. 2007;32(2):197-200.
30. Fernandez-Obregon A, Patton DL. The role of Chlamydia pneumoniae in the etiology of acne rosacea: response to the use of oral azithromycin. Cutis. 2007;79(2):163-167.
31. Rebora A. The management of rosacea. Am J Clin Dermatol. 2002;3(7):489-496.
32. Torresani C, Pavesi A, Manara GC. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol. 1997;36(12):942-946.
33. Bakar O, Demirçay Z, Gürbüz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol. 2004;43(2):151-154.
34. Pye RJ, Burton JL. Treatment of rosacea by metronidazole. Lancet. 1976;1(7971):1211-1212.
35. Saihan EM, Burton JL. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol. 1980;102(4):443-445.
36. Krause MH, Torricelli R, Kündig T, Trüeb RM, Hafner J. Dapsone in granulomatous rosacea. Hautarzt. 1997;48(4):246-248.
37. Fowler JF Jr. Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea. J Drugs Dermatol. 2007;6(6):641-645.
38. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51(4):499-512: quiz 513-514.
39. Aizawa H, Niimura M. Oral spironolactone therapy in male patients with rosacea. J Dermatol. 1992;19(5):293-297.
40. Park JH, Oh SM, Lim SS, et al. Induction of heme oxygenase-1 mediates the anti-inflammatory effects of the ethanol extract of Rubus coreanus in murine macrophages. Biochem Biophys Res Commun. 2006;351(1):146-152.
41. Mauss J. Cyproterone therapy of papulopustular rosacea in women. Hautarzt. 1981;32(2):94-95.
42. Spirov G, Berova N, Vassilev D. Effect of oral inhibitors of ovulation in treatment of rosacea and dermatitis perioralis in women. Australas J Dermatol. 1971;12(3):149-154.
43. Larson AA, Goldman MP. Recalcitrant rosacea successfully treated with multiplexed pulsed dye laser. J Drugs Dermatol. 2007;6(8):843-845.
44. Kawana S, Ochiai H, Tachihara R. Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg. 2007;33(4):449-454.
45. Laqueize S, Czernieleski J, Baltas E. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea. J Dermatol Treat. 2007;18(3):158-162.
46. Wu JJ, Weinstein GD, Kricorian GJ, Kormeili T, McCullough JL. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol. 2007;32(6):693-695.
47. Yu TG, Zheng YZ, Zhu JT, Guo W. Effect of treatment of rosacea in females by Chibixiao Recipe in combination with minocycline and spironolactone. Chin J Integr Med. 2006;12(4):277-280.